The client is one of the world’s leaders in the development of drugs for cancer treatment. The client’s holding company operates under two divisions (Pharmaceuticals and Diagnostics) and is listed among the Fortune 100. The firm employed a team of 70 medical writers, who would manually draft clinical study protocol documents necessary for submission to regulatory authorities and ethics committees. Typically, the writers would leverage multiple data sources in this effort, including historical protocols, online information, and internal repositories.